Sparton Corp. (SPA) 8.96 -0.03

Sparton Corp.
(SPA) 8.96 -0.03

Last Trade:	8.95	Day Range:	8.731 - 8.95
Trade Time:	06:05PM	52wk Range:	5.34 - 10.6392
Prev. Close:	8.98	Market Cap:	90.32M
Open:	8.90	Div Yield:	0
Volume:	7100	PE:
EPS:	0.49

The Latest On SPA

Sparton Corporation and USSI Joint Venture (SonobuoyTech Systems) Awarded $13.9M in Direct Foreign Sales Contracts 4/30/12 8:32am

Sparton Awarded $24.9 Million for Q53F, Q62E, and Q36B Sonobuoy Subcontracts 3/29/12 8:30am

Sparton Corporation Awarded $7.6M in Foreign Sonobuoy Contracts 2/6/12 9:44am

Sims Metal Management Makes a 20% Strategic Investment in Chiho-Tiande Group 1/17/12 10:25am

Cyclacel Provides Corporate Update at OneMedForum Conference; Re-Analysis "Insufficient" 1/11/12 1:27pm

Lannett Reaches Special Protocol Assessment Agreement with FDA for Cocaine HCl Phase III Trial 1/4/12 12:40pm

Investor Ideas: Tuesday's Biotech and Pharma Stocks to Watch 12/7/11 2:31pm

InterOil and ENN Sign Heads of Agreement for LNG Supply 12/2/11 9:01am

Investor Ideas: BioSante Pharmaceuticals Announces Issuance of New LibiGel® Method of Use Patent 11/29/11 12:16pm

Citigroup Raises PT on Cheniere Energy to $19 11/23/11 10:12am

Investor Ideas Biotech and Pharma Stocks News Alert: BioSante Pharmaceuticals Added to NASDAQ Biotechnology Index 11/21/11 2:46pm

Biotech Watchlist: BioSante Pharmaceuticals and Antares Pharma 11/16/11 1:14pm

Sparton Corporation and USSI Joint Venture (SonobuoyTech Systems) Awarded $13.9M in Direct Foreign Sales Contracts 4/30/12

Sparton Awarded $24.9 Million for Q53F, Q62E, and Q36B Sonobuoy Subcontracts 3/29/12

Sparton Corporation Awarded $7.6M in Foreign Sonobuoy Contracts 2/6/12

Sims Metal Management Makes a 20% Strategic Investment in Chiho-Tiande Group 1/17/12

Cyclacel Provides Corporate Update at OneMedForum Conference; Re-Analysis "Insufficient" 1/11/12

Lannett Reaches Special Protocol Assessment Agreement with FDA for Cocaine HCl Phase III Trial 1/4/12

Investor Ideas: Tuesday's Biotech and Pharma Stocks to Watch 12/7/11

InterOil and ENN Sign Heads of Agreement for LNG Supply 12/2/11

Investor Ideas: BioSante Pharmaceuticals Announces Issuance of New LibiGel® Method of Use Patent 11/29/11

Citigroup Raises PT on Cheniere Energy to $19 11/23/11

Investor Ideas Biotech and Pharma Stocks News Alert: BioSante Pharmaceuticals Added to NASDAQ Biotechnology Index 11/21/11

Biotech Watchlist: BioSante Pharmaceuticals and Antares Pharma 11/16/11

Q&A Interview with CEO of BioSante Pharmaceuticals Following News of Positive LibiGel® Safety Data Review in Phase III Program 10/24/11

Investors Seeing the Upside in BioSante Pharmaceuticals Following News of LibiGel® Positive Data 10/14/11

Biotech/Pharma stocks News; BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review in Phase III Program 10/11/11

Pharma/Biotech Investor Alert; BioSante Trading Up Over 10% on News of Top LibiGel Efficacy Trial Results 10/4/11

Biotech/Pharma stocks News; BioSante Pharmaceuticals, Inc. Completes Both Pivotal LibiGel® Efficacy Trials 10/4/11

Pharma/Biotech Stocks Reporting on Breast Cancer Treatments 9/23/11

Biotech/Pharma Stocks to Watch: BioSante, RXi, Dendreon, Catalyst Pharmaceutical Partners 9/13/11

Biotech and Pharma News; BioSante Pharmaceuticals Successfully Completes LibiGel® Pharmacokinetic Study 9/12/11

Biotech Investor Stock Alert; BioSante Trading its Way Back to $3.00 9/9/11

Monday's OTC Percentage Gainers 8/30/11

Investor FAQs and Facts for BioSante Pharmaceuticals, Inc 8/24/11

Biotech Investor Alert; BioSante Rebounds, Trading up over 14% 8/9/11

Citigroup Raises PT on Cheniere Energy to $19 11/23/11

Jefferies Maintains Hold Rating and $6 PT on Exelixis 11/1/11

UPDATE: J.P. Morgan Lowers Price Target on Exelixis to $5 11/1/11

J.P. Morgan Maintains Neutral Rating On SGEN 5/2/11

Trade SPA
NOW!

Partner Headlines

Sparton Corp. Reports Operating Results (10-Q) 5/8/12

Stoneridge Beats, Profits Up - Analyst Blog 5/7/12

Sparton Corp. (SPA) Sr. V.P./ CFO Greg Slome sells 3,465 Shares 5/4/12

Sparton Corp. (SPA) CEO and President Cary B Wood sells 4,620 Shares 5/4/12

Sparton Corp. (SPA) CEO and President Cary B Wood sells 4,128 Shares 5/1/12

Sparton Corp. (SPA) CEO, President Cary B Wood sells 2,064 Shares 4/11/12

Sparton Corp. (SPA) President and CEO Cary B Wood sells 3,692 Shares 4/6/12

Sparton Corp. (SPA) Sr. V.P./ CFO Greg Slome sells 2,770 Shares 4/6/12

Maxwell Gets Swiss Funding - Analyst Blog 2/24/12

Sparton Corp. Reports Operating Results (10-Q) 2/7/12

Press Releases

Sparton to Present at the East Coast IDEAS Investor Conference 5/29/12 Business Wire

Sparton To Present at the B. Riley Investor Conference 5/16/12 Business Wire

Sparton Corporation Reports $0.20 EPS for Fiscal 2012 Third Quarter; Adjusted EBITDA Increases 19% 5/8/12 Business Wire

Three Part Advisors Announces East Coast IDEAS Investor Conference 5/4/12 GlobeNewswire

Sparton Medical Recognized for Teaming with BioMarker Strategies and HS Design to Automate Live Tumor-Cell Processing 5/1/12 Business Wire

Sparton Corporation and USSI Joint Venture (SonobuoyTech Systems) Awarded $13.9M in Direct Foreign Sales Contracts 4/30/12 Business Wire

Sparton Corporation To Host Conference Call To Discuss Fiscal 2012 Third Quarter Financial Results 4/25/12 Business Wire

200 Public Companies Set to Present at B. Riley 13th Annual Investor Conference May 21-23, 2012 4/17/12 Business Wire

Allon Therapeutics announces private placement 4/16/12 Newswire

Sparton Corporation and USSI Joint Venture (SonobuoyTech Systems) Awarded $2.6M in Direct Foreign Sales Contracts 4/10/12 Business Wire

Sparton Introduces Innovative New Application for the GEDC-6 Gyro-Enhanced Digital Compass 4/4/12 Business Wire

Higher Reach by Jenzabar Named as CODiE Award Finalist 4/3/12 PRWeb

Get the latest SPA stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Sparton Corp. stock price.

Sparton Corp. by YCharts

Sparton Corp. (SPA) 8.96 -0.03

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On SPA

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social